- Home
- SOL vs CRVO Comparison
SOL vs CRVO Comparison
Compare SOL & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOL
- CRVO
- Stock Information
- Founded
- SOL 2005
- CRVO 2001
- Country
- SOL United States
- CRVO United States
- Employees
- SOL N/A
- CRVO N/A
- Industry
- SOL Semiconductors
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- SOL Technology
- CRVO Health Care
- Exchange
- SOL Nasdaq
- CRVO Nasdaq
- Market Cap
- SOL 94.9M
- CRVO 67.4M
- IPO Year
- SOL 2008
- CRVO N/A
- Fundamental
- Price
- SOL $1.91
- CRVO $5.65
- Analyst Decision
- SOL Strong Buy
- CRVO Strong Buy
- Analyst Count
- SOL 2
- CRVO 8
- Target Price
- SOL $4.50
- CRVO $25.57
- AVG Volume (30 Days)
- SOL 339.2K
- CRVO 136.8K
- Earning Date
- SOL 08-19-2025
- CRVO 08-08-2025
- Dividend Yield
- SOL N/A
- CRVO N/A
- EPS Growth
- SOL N/A
- CRVO N/A
- EPS
- SOL N/A
- CRVO N/A
- Revenue
- SOL $85,621,000.00
- CRVO $9,308,215.00
- Revenue This Year
- SOL N/A
- CRVO N/A
- Revenue Next Year
- SOL $45.37
- CRVO N/A
- P/E Ratio
- SOL N/A
- CRVO N/A
- Revenue Growth
- SOL N/A
- CRVO 15.14
- 52 Week Low
- SOL $1.04
- CRVO $1.80
- 52 Week High
- SOL $3.00
- CRVO $20.63
- Technical
- Relative Strength Index (RSI)
- SOL 62.80
- CRVO 32.36
- Support Level
- SOL $1.84
- CRVO $6.31
- Resistance Level
- SOL $1.91
- CRVO $7.20
- Average True Range (ATR)
- SOL 0.05
- CRVO 0.52
- MACD
- SOL -0.00
- CRVO -0.10
- Stochastic Oscillator
- SOL 95.65
- CRVO 9.20
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.